A detailed history of Tsp Capital Management Group, LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 216,625 shares of ASRT stock, worth $194,962. This represents 0.09% of its overall portfolio holdings.

Number of Shares
216,625
Previous 218,325 0.78%
Holding current value
$194,962
Previous $270,000 5.56%
% of portfolio
0.09%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$1.07 - $1.75 $1,819 - $2,975
-1,700 Reduced 0.78%
216,625 $255,000
Q2 2024

Jul 23, 2024

BUY
$0.75 - $1.31 $2,868 - $5,010
3,825 Added 1.78%
218,325 $270,000
Q1 2024

Apr 30, 2024

BUY
$0.79 - $1.14 $26,504 - $38,247
33,550 Added 18.54%
214,500 $205,000
Q4 2023

Jan 16, 2024

BUY
$1.02 - $2.57 $23,613 - $59,495
23,150 Added 14.67%
180,950 $193,000
Q3 2023

Nov 07, 2023

BUY
$2.52 - $5.69 $3,024 - $6,828
1,200 Added 0.77%
157,800 $403,000
Q2 2023

Jul 19, 2023

SELL
$5.0 - $7.66 $15,000 - $22,980
-3,000 Reduced 1.88%
156,600 $848,000
Q1 2023

Apr 13, 2023

SELL
$3.54 - $6.66 $165,137 - $310,682
-46,649 Reduced 22.62%
159,600 $1.02 Million
Q4 2022

Jan 17, 2023

SELL
$2.11 - $4.3 $6,330 - $12,900
-3,000 Reduced 1.43%
206,249 $0
Q3 2022

Oct 20, 2022

SELL
$2.13 - $4.0 $44,623 - $83,800
-20,950 Reduced 9.1%
209,249 $475,000
Q1 2022

May 12, 2022

SELL
$2.06 - $3.0 $6,077 - $8,850
-2,950 Reduced 1.27%
230,199 $661,000
Q4 2021

Jan 26, 2022

SELL
$0.86 - $2.3 $30,508 - $81,592
-35,475 Reduced 13.21%
233,149 $508,000
Q3 2021

Nov 03, 2021

BUY
$0.89 - $1.55 $122,708 - $213,706
137,875 Added 105.45%
268,624 $243,000
Q2 2021

Aug 13, 2021

BUY
$1.48 - $2.88 $193,508 - $376,557
130,749 New
130,749 $204,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $43.4M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Tsp Capital Management Group, LLC Portfolio

Follow Tsp Capital Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsp Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsp Capital Management Group, LLC with notifications on news.